Sigma-Aldrich Posts 4 Percent Q2 Sales Growth, Misses Street Expectation | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 4 percent but fell short of analysts' expectations for the top line.

The St. Louis-based research and chemical products firm reported total revenues of $664 million for the three months ended June 30, up from $637 million for the second quarter of 2011. Analysts, on average, expected sales of $674.7 million.

On an organic basis, Sigma-Aldrich's sales grew 3 percent. Acquisitions added 6 percent to sales growth, while currency exchange reduced its sales by 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.